| PICTET - BIOTECH P EUR | RVI BIOTECNOLOGÍA | 71,67% | 93,68% | 69,05% | 147,04% |
| T.ROWE FRONTIER MARKETS EQUITY FUND Q | RVI EMERGENTES | 18,66% | 64,92% | 69,05% | 150,46% |
| UBS (LUX) EQUITY SICAV - GLOBAL HIGH DIVIDEND (USD) (EUR HEDGED) Q-ACC | RVI GLOBAL VALOR | 34,68% | 67,52% | 69,04% | 126,58% |
| BARING GLOBAL RESOURCES FUND A GBP DIS | RVI MATERIAS PRIMAS | 42,50% | 43,06% | 69,03% | 96,09% |
| PICTET - BIOTECH P USD | RVI BIOTECNOLOGÍA | 71,81% | 94,33% | 69,02% | 146,49% |
| PICTET - BIOTECH P DY USD | RVI BIOTECNOLOGÍA | 71,81% | · | 69,01% | 146,51% |
| SCHRODER ISF JAPANESE OPPORTUNITIES A ACC JPY | RVI JAPÓN VALOR | 33,03% | 64,52% | 68,99% | 121,28% |
| AMUNDI MSCI NORTH AMERICA ESG BROAD TRANSITION AE DIS | RVI USA | 21,63% | 61,81% | 68,98% | 227,55% |
| BANKINTER SOSTENIBILIDAD, FI C | RVI GLOBAL | 25,33% | 57,67% | 68,98% | · |
| WELLINGTON DOWNSIDE ALPHA OPPORTUNITIES S USD ACC | RVI GLOBAL | 20,27% | 55,43% | 68,95% | · |
